Melanotan II is one of the most-searched melanocortin research peptides in Australia. This page covers what it is, the research areas it appears in, and how to source it with documentation from local stock.

What is Melanotan II?

Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) with broad activity across the melanocortin receptors.

Two features of its structure define it. The first is that it is cyclic — the peptide chain is closed into a ring rather than left as a linear strand. Natural α-MSH is linear and degrades quickly; closing the ring locks the molecule into a fixed shape and makes it far more resistant to enzymatic breakdown. The second is that it is truncated: α-MSH is thirteen amino acids, Melanotan II is seven. It keeps the core sequence responsible for receptor binding and discards the rest.

The result is a smaller, more stable molecule that is also markedly non-selective. Where a designed drug usually aims at one receptor, Melanotan II binds across most of the melanocortin family — MC1, MC3, MC4 and MC5. That lack of selectivity is precisely why it appears so often in receptor-mapping research: it activates the whole system at once, which is useful when the question is what each receptor contributes.

Melanotan II, Melanotan I and PT-141

These three are constantly confused with one another, and the distinction is receptor selectivity:

  • Melanotan I (afamelanotide) — a linear analogue, comparatively selective for the MC1 receptor, the one associated with pigmentation research.
  • Melanotan II — cyclic and non-selective, binding across MC1, MC3, MC4 and MC5.
  • PT-141 (bremelanotide) — a metabolite of Melanotan II. When Melanotan II breaks down in the body, PT-141 is one of the products. It lacks the group responsible for MC1 activity, leaving it focused on the MC4 receptor.

So the family isn't three unrelated compounds — it's one structural lineage narrowing from broad to specific. Our Melanotan I vs II guide and Melanotan II vs PT-141 comparison go through each pairing.

Research areas

In the scientific literature, Melanotan II is studied in relation to:

  • Skin pigmentation and tanning research
  • Melanocortin-system research
  • MC1 receptor-pathway research
  • MC3 / MC4 / MC5 receptor-selectivity research
  • Structure–activity research across melanocortin analogues

These describe fields of scientific study — they are not claims about effects in humans. Nothing here should be read as a statement about what the compound does in a person; NextGen Peptides supplies it strictly for laboratory and in-vitro research use.

The reason it spans so many receptor subtypes in the literature is the non-selectivity described above. A compound that engages four receptors at once is a blunt instrument therapeutically but a genuinely useful research tool — comparing its effects against a selective analogue like Melanotan I is one of the standard ways the field isolates what any individual receptor is doing.

Storage & handling

Supplied as a lyophilised (freeze-dried) powder. Store at −20°C; reconstitute with bacteriostatic water and refrigerate after mixing. See our full guide to storing and reconstituting research peptides, and what to mix it with in our bacteriostatic water guide.

The cyclic structure makes this one comparatively robust as research peptides go — the closed ring resists degradation better than a linear chain. That's a margin of safety, not permission to be careless. The essentials still apply: reconstitute by running diluent slowly down the vial wall and swirling rather than shaking, refrigerate at 2–8°C once mixed, keep it out of light, and never refreeze a reconstituted solution. Concentration is set by the diluent volume you choose — our reconstitution calculator does the arithmetic.

Sourcing Melanotan II in Australia

We hold Melanotan II in Australian stock, so orders placed before the daily cut-off are dispatched same or next business day — no overseas freight, no customs wait. Every batch is independently third-party tested, with the Certificate of Analysis published. New to buying research peptides? Read our Australian buyer’s guide first.

Common questions about Melanotan II

What is Melanotan II?
A synthetic cyclic analogue of α-melanocyte-stimulating hormone (α-MSH) with broad activity across the melanocortin receptors. Supplied for laboratory research use only.

What research areas is Melanotan II studied in?
Skin pigmentation and tanning research, melanocortin-system research, and MC1 receptor-pathway research. These are fields of study, not effects in humans.

Is Melanotan II tested and does it come with a CoA?
Yes. Every batch is independently tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published.

Is Melanotan II held in Australian stock?
Yes. We hold Melanotan II in Australian stock and dispatch same or next business day for orders placed before the daily cut-off.

What's the difference between Melanotan I and Melanotan II?
Selectivity. Melanotan I is linear and comparatively selective for the MC1 receptor. Melanotan II is cyclic and non-selective, binding across MC1, MC3, MC4 and MC5. See our full comparison.

How is Melanotan II related to PT-141?
PT-141 (bremelanotide) is a metabolite of Melanotan II — one of the products formed when it breaks down. It lacks the group responsible for MC1 activity, which leaves it focused on the MC4 receptor.

Why is it described as cyclic?
The peptide chain is closed into a ring rather than left as an open strand. That locks the molecule into a fixed shape and makes it considerably more resistant to enzymatic breakdown than linear α-MSH.

How long does a reconstituted vial last?
Generally around four weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Unreconstituted powder at −20°C keeps far longer. Never refreeze a reconstituted solution.

Does it need cold-chain shipping?
No. Lyophilised powder is stable in transit. Orders ship from Melbourne in discreet, unmarked packaging with tracking — see shipping & delivery.

Legal status and intended use

Melanotan II is supplied by NextGen Peptides strictly as a research chemical for laboratory and in-vitro use. It is not an approved therapeutic good in Australia, it is not supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over. For the regulatory framework, see our guide to the legal status of research peptides in Australia.

Related research

Explore related compounds held in Australian stock: PT-141.

Further reading: Melanotan I vs Melanotan II.

Shop Melanotan II

Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.